Assessing the effect of nicotine reduction on ENDS user's addiction and exposures
评估减少尼古丁对电子尼古丁传送系统使用者成瘾和接触的影响
基本信息
- 批准号:10487515
- 负责人:
- 金额:$ 41.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-15 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AbstinenceAcuteAddressAerosolsAffectAldehydesBehaviorBrainCharacteristicsCigaretteCigarette SmokerClinicalClinical TrialsCountryDependenceDiffuseDoseElectronic Nicotine Delivery SystemsElectronic cigaretteEmerging Tobacco ProductsEpidemicExposure toEyeFinancial compensationFormulationFrequenciesFutureGenerationsGoalsHourIntakeIntentionJUULLiquid substanceLungLung diseasesMeasuresMethodsNauseaNicotineNicotine DependenceObservational StudyOutcomeOxygen saturation measurementPalpitationsParticipantPatternPersonsPlasmaPoisonProtocols documentationPulmonary Function Test/Forced Expiratory Volume 1RegulationReportingRiskRobotRoleSaltsSmokeSmokerSmokingStandardizationSymptomsTimeTobacco useToxicant exposureUnited StatesUnited States Food and Drug AdministrationWithdrawalXerostomiaYouthaddictioncigarette smokingclinical effectcravingepidemiology studyfollow-upirritationliquid nicotinelow nicotine content cigarettenicotine exposurenicotine usepreferencepublic health relevancepulmonary functionrecruitrespiratoryresponsesatisfactionside effectsmoking initiationtobacco productstoxicanttrendvapor
项目摘要
PROJECT SUMMARY
The use of electronic nicotine delivery systems (ENDS or e-cigarettes) has reached epidemic levels among
young people in the United States (US). ENDS emit toxic substances, including nicotine that irreversibly affects
the developing brain and leads to dependence and increased risk of cigarette smoking initiation. Evidence
indicates that young people using ENDS are likely to accelerate use and become nicotine dependent. Some of
the most popular ENDS among youth (e.g. JUUL with 5% nicotine liquid) deliver in one cartridge a nicotine
dose equal to an entire pack of cigarettes, and many users are unaware of this substantial exposure and the
related risk of addiction. On the other hand, nicotine reduction (NR) has been considered by the US Food and
Drug Administration (FDA) as an important strategy to limit the addictiveness and use of tobacco products.
Now that the FDA regulates ENDS under the “deeming rule”, such a strategy can be considered for these
emerging tobacco products. However, we still lack evidence on the expected effects of a range of NR levels on
ENDS users at different stages of use trajectory. Using clinical and analytical lab methods we plan to compare
among 5% nicotine ENDS users the effect of partial (3%) or total (nicotine-free, 0%) NR on users' dependence,
satisfaction, clinical (e.g. BP, oximetry, lung functions, symptoms), puffing behavior, and exposure to toxicants.
We will recruit current ENDS users (n=120; 21-35 yrs), for a 3X2X2 within-between subject crossover lab
study. Because the effect of NR on ENDS users will likely vary by frequency and stage of ENDS use, we will
study NR effects in high vs. low-frequency users (use on ≥ 20 vs. < 20 days/past month). Therefore, the 3
nicotine conditions (5%, 3%, 0%) x 2 times (pre-post) are the within-subject factors, while the frequency of use
is the between-subject factor. We hypothesize that NR will be associated with less satisfaction, withdrawal
suppression, and intention to use and that such an effect will be more pronounced in total compared to partial
NR and among high compared to low-frequency users. The proposed studies aim to answer 3 main regulatory
questions: 1) is NR a promising regulatory option to reduce ENDS addictiveness and use; 2) what is the effect
of partial vs. total NR on compensatory puffing and exposure to nicotine and respiratory toxicants, and 3) what
is the effect of NR on ENDS users at different stages of their use. Combined, these studies will give direct and
standardized evidence on the potential of NR regulations to limit the addictiveness and use of ENDS, and to
help predict any potential side effects of NR on ENDS users' exposure to harmful toxicants.
项目摘要
电子尼古丁输送系统(ENDS或电子烟)的使用已达到流行程度
美国的年轻人(US)。ENDS会释放有毒物质,包括尼古丁,对人体产生不可逆转的影响
大脑发育,导致依赖性和吸烟开始的风险增加。证据
表明使用ENDS的年轻人可能会加速使用并成为尼古丁依赖者。一些
年轻人中最流行的ENDS(例如含有5%尼古丁液体的JUUL)在一个药筒中提供尼古丁
剂量等于一整包香烟,许多用户不知道这种实质性的接触,
成瘾的相关风险。另一方面,美国食品和药物管理局已考虑减少尼古丁(NR),
美国食品药品监督管理局(FDA)作为一个重要的战略,以限制烟草制品的成瘾性和使用。
既然FDA根据“推定规则”对ENDS进行了监管,那么可以考虑这样的策略。
新兴烟草产品。然而,我们仍然缺乏证据表明一系列NR水平对
在使用轨迹的不同阶段结束用户。使用临床和分析实验室方法,我们计划比较
在5%的尼古丁ENDS使用者中,部分(3%)或全部(无尼古丁,0%)NR对使用者依赖性的影响,
满意度、临床(例如BP、血氧测定、肺功能、症状)、吸烟行为和毒物暴露。
我们将招募当前ENDS用户(n=120; 21-35岁),用于3X 2X2受试者间交叉实验室
study.由于NR对ENDS使用者的影响可能会因ENDS使用的频率和阶段而异,我们将
研究高频率与低频率使用者的NR效应(使用≥ 20天与< 20天/过去一个月)。因此,3
尼古丁条件(5%、3%、0%)× 2次(术前、术后)是受试者内因素,而使用频率
是受试者之间的因素。我们假设NR将与较低的满意度,退出,
抑制,并打算使用,这样的效果将更明显,在整体相比,部分
NR和之间的高频率用户相比。这些研究旨在回答3个主要的监管问题。
问题:1)NR是一个有希望的监管选择,以减少ENDS成瘾和使用; 2)效果如何
部分NR与总NR对代偿性抽吸和暴露于尼古丁和呼吸道毒物的影响,以及3)
是NR对ENDS使用者在不同使用阶段的影响。结合起来,这些研究将提供直接和
关于NR法规限制ENDS成瘾性和使用的潜力的标准化证据,
帮助预测NR对ENDS使用者暴露于有害毒物的任何潜在副作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Wasim Maziak其他文献
Wasim Maziak的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Wasim Maziak', 18)}}的其他基金
The effect of menthol on ENDS users' dependence, respiratory, and toxicants emission outcomes
薄荷醇对 ENDS 用户的依赖性、呼吸系统和毒物排放结果的影响
- 批准号:
10444519 - 财政年份:2022
- 资助金额:
$ 41.07万 - 项目类别:
The effect of menthol on ENDS users' dependence, respiratory, and toxicants emission outcomes
薄荷醇对 ENDS 用户的依赖性、呼吸系统和毒物排放结果的影响
- 批准号:
10595647 - 财政年份:2022
- 资助金额:
$ 41.07万 - 项目类别:
Assessing the effect of nicotine reduction on ENDS user's addiction and exposures
评估减少尼古丁对电子尼古丁传送系统使用者成瘾和接触的影响
- 批准号:
10351405 - 财政年份:2021
- 资助金额:
$ 41.07万 - 项目类别:
Understanding tobacco flavor effects on waterpipe smokers’ experiences and exposures
了解烟草味道对水烟吸烟者体验和接触的影响
- 批准号:
9185394 - 财政年份:2016
- 资助金额:
$ 41.07万 - 项目类别:
Advancing addiction research and capacity to guide tobacco control in the Eastern
推进成瘾研究和指导东部地区烟草控制的能力
- 批准号:
8332504 - 财政年份:2012
- 资助金额:
$ 41.07万 - 项目类别:
Advancing addiction research and capacity to guide tobacco control in the Eastern
推进成瘾研究和指导东部地区烟草控制的能力
- 批准号:
9316565 - 财政年份:2012
- 资助金额:
$ 41.07万 - 项目类别:
Advancing addiction research and capacity to guide tobacco control in the Eastern
推进成瘾研究和指导东部地区烟草控制的能力
- 批准号:
8526443 - 财政年份:2012
- 资助金额:
$ 41.07万 - 项目类别:
Advancing addiction research and capacity to guide tobacco control in the Eastern
推进成瘾研究和指导东部地区烟草控制的能力
- 批准号:
9117533 - 财政年份:2012
- 资助金额:
$ 41.07万 - 项目类别:
Responding to the changing tobacco epidemic in the Eastern Mediterranean Region
应对东地中海地区不断变化的烟草流行
- 批准号:
7500669 - 财政年份:2007
- 资助金额:
$ 41.07万 - 项目类别:
Responding to the changing tobacco epidemic in the Eastern Mediterranean Region
应对东地中海地区不断变化的烟草流行
- 批准号:
7925647 - 财政年份:2007
- 资助金额:
$ 41.07万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 41.07万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 41.07万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 41.07万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 41.07万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 41.07万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 41.07万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 41.07万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 41.07万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 41.07万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 41.07万 - 项目类别:
Standard Grant